Trial Profile
A proof-of-concept, observational study to evaluate intravenous lacosamide as treatment option in post-stroke non convulsive status epilepticus in the elderly
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Nov 2015
Price :
$35
*
At a glance
- Drugs Lacosamide (Primary)
- Indications Status epilepticus
- Focus Proof of concept; Therapeutic Use
- 26 Nov 2015 New trial record